Kratom's Neural Circuitry Decoded: Review Maps Brain Reward and Cognitive Pathways

Why it matters

Clinicians and regulators need a clearer picture of how kratom alters brain function — this review synthesizes current evidence on neural circuits involved in addiction, reward, and cognitive impairment to guide better policy and care.

The big picture

Kratom use has surged globally, but its neurobiological effects remain poorly documented. While mitragynine and 7-hydroxymitragynine are the most studied alkaloids, at least 54 compounds have been identified in kratom leaves. This review from researchers at Universiti Sains Malaysia and Macquarie University brings together preclinical and limited human data to map how these compounds interact with opioid, dopaminergic, serotonergic, and adrenergic pathways across brain regions.

Key findings

• Mitragynine and 7-OH act as G-protein-biased partial agonists at mu-opioid receptors, potentially avoiding some respiratory depression risks of classical opioids
• Kratom modulates the mesolimbic reward circuit (VTA-nucleus accumbens), producing reinforcement and mild euphoria less pronounced than morphine but capable of driving compulsive use
• Higher doses and chronic use are linked to cognitive impairment, hippocampal disruption, and possible organ toxicity including hepatotoxicity
• Kratom alkaloids also interact with serotonergic and adrenergic systems, contributing to dose-dependent stimulant or sedative effects
• Most evidence remains preclinical and concurrent substance use complicates clinical interpretation — translational gaps persist

What they say

The authors write that "kratom exhibits considerable pharmacological complexity, with its effects on neurocircuitry, behaviour and cognition arising from the interplay of numerous bioactive alkaloids that may produce complementary or opposing actions across multiple neurobiological targets."

Bottom line

Kratom rewires reward and cognitive brain circuits in dose-dependent ways — chronic exposure can produce dependence through the same neural mechanisms as classical opioids, making clinical monitoring essential.